The Saint Louis University Mental Status (SLUMS) Examination is a relatively new brief cognitive screening measure developed for use with veterans. To date, there has been a paucity of research on its psychometric properties. Using a sample of 148 male veterans referred to a VA Mild Cognitive Impairment (MCI) Clinic for evaluation, the SLUMS’ ability to discriminate between MCI versus other diagnoses or no diagnosis was compared to results from a more comprehensive neuropsychological battery. Approximately 51% of the sample was diagnosed with MCI, 16% with Major Depressive Disorder (MDD), 17% did not meet criteria for a diagnosis, and 16% were given some other DSM-IV-TR diagnosis. The SLUMS demonstrated poor internal consistency (Cronbach’s alpha = .57), but scores were significantly correlated with scores on every neuropsychological measure, except for Trails B. Diagnostic discriminability was comparable to that of the more time intensive neuropsychological battery for discriminating between MCI and no diagnosis, and MCI and MDD. In the current sample, a cutoff score of 25 was optimal for discriminating between MCI and no diagnosis, whereas a slightly lower cutoff score of 24 is recommended for discriminating between MCI and those with MDD. Diagnostic indicators were poor for the SLUMS and the battery when discriminating between MCI and a heterogeneous group of other disorders. Possible reasons for low reliability in such a screening measure in the context of convergent validity are discussed. It is concluded that the SLUMS may be a viable brief cognitive screening measure in such veteran populations, particularly when discriminating between MCI and MDD; however, additional studies should be completed to evaluate other forms of consistency, such as test-retest reliability.

The purpose of the present study was to construct and validate a brief screening instrument to support parent(s) and preschool/kindergarten teachers in monitoring and screening for cognitive impairment and/or delay in preschoolers. The target population of interest is all preschoolers <i>at-risk</i> for poor psychosocial and school outcomes due to chronic and acute dysfunction of the central nervous system (CNS). The accessible populations of interest to the present study are pediatric cancer survivors, preschoolers with alcohol related neurodevelopmental disorder (ARND), being preterm low birth weight, and/or diagnosed with various learning disabilities. The past practice of waiting until an <i>at-risk</i> child experienced poor school outcomes before being referred for cognitive assessment toward tailoring an intervention is no longer defensible. For the present study, a 61-item screening instrument (18 memory items, 19 verbal ability items, 15 attention items, and 9 demographic items) was pilot tested with parents, playschool teachers, and kindergarten teachers to rate preschoolers on overt behaviours associated with cognitive functioning. A criterion-referenced framework was used to establish a performance standard and set a cut score based on a sample of 151 normally functioning preschoolers aged 4:0- to 5:11-years. The various empirical and substantive analyses conducted resulted in a revised scale of 28 items (10 memory, 11 verbal ability, and 7 attention) titled, <i>Screening Test for the Early Prediction of School Success</i> (STEPSS). Given the need for a future study to validate the STEPSS with clinical groups of preschoolers, the screening instrument is intended to provide the empirical evidence needed to refer <i>at-risk</i> preschoolers for assessment with more comprehensive cognitive batteries. Constructing and validating the STEPSS is important for two reasons: 1) to fill a gap in the types of instruments available for monitoring and assessing cognitive functioning in <i>at-risk</i> preschool populations; and 2) to alleviate the current delay in targeting interventions for preschoolers because of the practice of depending upon the school system to monitor and identify poor cognitive functioning.

The purpose of the present study was to construct and validate a brief screening instrument to support parent(s) and preschool/kindergarten teachers in monitoring and screening for cognitive impairment and/or delay in preschoolers. The target population of interest is all preschoolers <i>at-risk</i> for poor psychosocial and school outcomes due to chronic and acute dysfunction of the central nervous system (CNS). The accessible populations of interest to the present study are pediatric cancer survivors, preschoolers with alcohol related neurodevelopmental disorder (ARND), being preterm low birth weight, and/or diagnosed with various learning disabilities. The past practice of waiting until an <i>at-risk</i> child experienced poor school outcomes before being referred for cognitive assessment toward tailoring an intervention is no longer defensible. For the present study, a 61-item screening instrument (18 memory items, 19 verbal ability items, 15 attention items, and 9 demographic items) was pilot tested with parents, playschool teachers, and kindergarten teachers to rate preschoolers on overt behaviours associated with cognitive functioning. A criterion-referenced framework was used to establish a performance standard and set a cut score based on a sample of 151 normally functioning preschoolers aged 4:0- to 5:11-years. The various empirical and substantive analyses conducted resulted in a revised scale of 28 items (10 memory, 11 verbal ability, and 7 attention) titled, <i>Screening Test for the Early Prediction of School Success</i> (STEPSS). Given the need for a future study to validate the STEPSS with clinical groups of preschoolers, the screening instrument is intended to provide the empirical evidence needed to refer <i>at-risk</i> preschoolers for assessment with more comprehensive cognitive batteries. Constructing and validating the STEPSS is important for two reasons: 1) to fill a gap in the types of instruments available for monitoring and assessing cognitive functioning in <i>at-risk</i> preschool populations; and 2) to alleviate the current delay in targeting interventions for preschoolers because of the practice of depending upon the school system to monitor and identify poor cognitive functioning.

Abstract: Determine the level of concordance between the Mini-Mental State Examination (MMSE), Short Portable Mental State Examination (SPMSQ), and Montreal Cognitive Assessment (MoCA) screening test for cognitive impairment in older adults. A cross-sectional study based on an original cohort study. 1683 patients over 60 years-old were included between 2010 and 2015. Demographic information was collected and the MMSE, MoCA, and SPMSQ scores were obtained. Categorical variables were presented as frequencies and percentages, while numerical ones as median and interquartile range. The agreement was measured and adjusted by the number of years of education by Cohen’s Kappa index (k) with a 95% confidence interval (CI). The agreement was considered as good if k > 0.80. MMSE classified 43.32% of the patients as having cognitive impairment, MoCA 43.14%, and SPMSQ 24.84%. MMSE and MoCA showed an agreement (k) of 0.99 with a 95% CI of 0.99–1.00; MoCA and SPMSQ showed a k of 0.43 (95% CI: 0.38–0.46). Finally, MMSE and SPMSQ showed a k of 0.42 (95% CI: 0.37–0.46). The results did not change when performing the analysis by education subgroups. There was a strong concordance between MoCA and MMSE tests. Nevertheless, the SPMSQ was discordant with the other tests. / Revisión por pares

OBJECTIVE: The goal of this research was to examine the clinical utility of the digital Clock in the Box (dCIB), a novel digitized cognitive screening test. This was accomplished by (1) creating cutoff scores for the dCIB, (2) evaluating performance on the dCIB relative to established cognitive screening and standardized neuropsychological measures, and (3) determining the efficacy of the dCIB to screen for subtle cognitive deficits associated with poor vascular health. Metabolic Syndrome (MetS; clinical syndrome of three or more cardiovascular risk factors) is a rising health epidemic associated with an increased risk for cerebrovascular disease and vascular dementia. Early detection of subtle deficits associated with MetS may assist in regulation of disease progression and prevention of future vascular dementia. METHODS: A community-based sample of adults with no self-reported history of cognitive impairment was recruited for a cross-sectional study in which they completed a metabolic assessment, blood draw, and a brief neuropsychological battery consisting of the dCIB, the Mini-Mental State Exam (MMSE), and measures of executive function, memory, and attention. For part of the analysis, participants were separated into MetS (n=21) and non-MetS (n=42) groups based on current diagnostic criteria for MetS. RESULTS: Participants (N=63) were older (62.49 ± 9.16 years), educated (16.46 ± 2.76 years), and diverse with 44.4% female (n=28) and 28.6% non-White (n=18). Receiver operating characteristic (ROC) analysis and Youden’s J statistic determined the optimal cutoff value for the dCIB as 5.5 (dCIB score ≤ 6 indicating suspected impairment; dCIB score ≤ 5 indicating probable impairment). Performance on the dCIB (6.32 ± 2.32) was significantly correlated with the MMSE (28.19 ± 2.06); (Pearson’s r = 0.437, p = 0.000). The dCIB had better sensitivity (72.7%) but poorer specificity (65.4%) compared to the MMSE (sensitivity 45.5%; specificity 94.2%). Using regression modeling, the dCIB significantly predicted performance on measures of executive function, memory, and attention. In a sample stratified by vascular risk, the dCIB successfully differentiated MetS (5.33 ± 2.75) and non-MetS (6.81 ± 1.93) groups, with lower dCIB scores in the MetS group relative to the non-MetS group (F = 8.975, p = 0.004). CONCLUSION: The dCIB is a novel digitized clock drawing task designed to screen for cognitive impairment. Clinical utility for the dCIB was established by determining its test validity and demonstrating its sensitivity to detect subtle cognitive deficits in a sample with vascular risk. Because the dCIB is simple to administer and brief to complete, it may be an ideal option for routine cognitive screening in primary care settings.

Esta tese de doutorado aborda aspectos teóricos e empíricos da avaliação neuropsicológica nas doenças cerebrovasculares, ao propor a construção de um instrumento do tipo triagem cognitiva. A tese foi dividida em quatro estudos. O Estudo 1 apresenta etapas e critérios necessários para construir e adaptar instrumentos neuropsicológicos. Nesse estudo, destacouse que ao construir um teste é importante ter uma teoria que embase o desenvolvimento dos itens, além do aporte da psicometria, neuropsicolinguística, psicologia experimental e modelos de processamento da informação. O Estudo 2 trata de uma revisão sistemática que analisou as propriedades psicométricas dos instrumentos neuropsicológicos aplicados em amostras com AVC e o desempenho dos pacientes nesses estudos. Concluiu-se que muitas pesquisas utilizam instrumentos desenvolvidos com o propósito de avaliar pacientes com demência, pouco sensíveis para adultos pós AVC. Os principais déficits cognitivos dessa doença envolvem a velocidade do processamento, visuoconstrução, memória episódica, atenção e funções executivas, que devem ser incluídas em baterias de avaliação neuropsicológica. No Estudo 3 investigou-se empiricamente quais tarefas mostram-se importantes para avaliar pacientes pós AVC. Ao analisar o desempenho por itens em um instrumento de avaliação neuropsicológica breve, identificou-se que tarefas de orientação, linguagem oral, habilidades acadêmicas (leitura, escrita e aritmética) e funções executivas melhor discriminam entre grupos com AVC e saudáveis. O Estudo 4 apresenta o processo de construção e as propriedades psicométricas da Triagem Cognitiva (TRIACOG) para avaliar adultos com doenças cerebrovasculares. O TRIACOG passou por etapas rigorosas de revisão da literatura, análise de juízes, estudos piloto e aplicação em 100 adultos pós AVC e 100 adultos neurologicamente saudáveis. O instrumento apresenta evidências de validade baseadas no conteúdo, na relação com outras variáveis (critério e validade convergente), no processo de resposta; e evidências de fidedignidade teste-reteste e entre avaliadores. Espera-se que esses estudos possam orientar pesquisadores que pretendem construir instrumentos neuropsicológicos e contribuir com uma ferramenta que pode ser utilizada no contexto clínico, hospitalar e de pesquisa, por profissionais da saúde. / This doctoral dissertation discusses theoretical and empirical aspects of the neuropsychological assessment in cerebrovascular diseases, proposing the construction of a cognitive screening instrument. The thesis was divided into four studies. The Study 1 presents steps and criteria to construct and adapt neuropsychological instruments. In this study, was highlighted the importance to have a theoretical basis to development the items of a test, besides the contribution of psychometry, neuropsycholinguistics, experimental psychology and information processing models. The Study 2 is a systematic review that analyzed the psychometric properties of neuropsychological instruments to evaluate stroke samples and the performance of patients assessed by the studies. It was concluded that many researches use instruments developed for evaluating patients with dementia, not sensitive to adults poststroke. The main deficits of this disease involve processing speed, visuoconstruction, episodic memory, attention and executive functions, which should be included in neuropsychological batteries. The Study 3 empirically investigated which tasks are important for evaluating poststroke patients. When analyzing the performance by items in a brief neuropsychological evaluation instrument, were identified that orientation, oral language, academic abilities (reading, writing and arithmetic) and executive functions tasks best discriminated between clinical and healthy groups. The Study 4 presents the construction and the psychometric properties of Cognitive Screening (TRIACOG) to evaluate adults post cerebrovascular disease. TRIACOG has undergone rigorous steps: literature review, pilot studies, and application in 100 post-stroke adults and 100 neurologically healthy adults. The instrument presents evidence of validity based on content, on relation to other variables (criterion and convergent validity) and on response processes; and test-retest and inter-rater reliability evidences. It is intended that these studies may guide researchers who want to build neuropsychological instruments and contribute with a tool that can be used in the clinical, hospital and research contexts, by health professionals.

Many standardized measures of cognition include items that must be seen or heard. Nevertheless, it is not uncommon to overlook the possible effects of sensory impairment(s) on test scores. In the current study, we investigated whether sensory impairments could affect performance on a widely used screening tool, the Montreal Cognitive Assessment (MoCA). Three hundred and one older adults (mean age = 71 years) completed the MoCA and also hearing and vision tests. Half of the participants had normal hearing and vision, 38% impaired hearing, 5% impaired vision, and 7% had dual-sensory impairment. More participants with normal sensory acuity passed the MoCA compared to those with sensory loss, even after modifying scores to adjust for sensory factors. The results suggest that cognitive abilities may be underestimated if sensory problems are not considered and that people with sensory loss are at greater risk of cognitive decline.

Cognitive impairment is commonly seen in the elderly population. It is unclear if cognitive deficit in heart failure (HF) patients is a primary factor for higher hospital readmission rates in this population. The Centers for Medicare and Medicaid Services have established strict guidelines for reimbursement on readmissions that occur within 30 days. It is imperative that organizations identify and rectify issues that impact readmissions. The aim of this project was to determine if there is a reduction in HF readmission after patients are screened for cognitive impairment. Orem's self-care model guided the project by providing a framework of inquiry regarding the impact of cognitive impairment on self-care deficits and the need for support for persons with heart failure. The project examined the hospital's 30-day readmission rate for the HF patients who received cognitive screening using a chi-square test; this analysis excluded HF patients who were not screened for cognitive impairment. Readmission rates for all patients during a 6-month period were examined. Two hundred sixty-eight patient records were reviewed; 48 patients were readmitted, and of those, 28 patients had completed the cognitive assessment, meeting the criteria for the project. The change in readmission rates was not significant (p = 0.196), suggesting that cognitive screening of patients is not associated with reduced readmission rates. Further research should examine the role of cognitive screening in addition to other resources on the 30-day readmission rate of HF patients. Social change will be improved as a result of the improved quality of life for HF patients and the reduced per-capita cost of health care in the United States.

Base teórica: Apesar de o escore da soma das caixas da escala de avaliação clínica da demência (CDR-SB) ser amplamente utilizado, sua aplicabilidade na avaliação do estadiamento da gravidade da demência e sua acurária para detectar as categorias diagnósticas não foram normatizadas em várias partes do mundo, inclusive no Brasil. Objetivo: O objetivo deste estudo foi avaliar a validade diagnóstica de CDR-SB na detecção e no estadiamento do comprometimento cognitivo e da demência em uma amostra de pacientes brasileiros com comprometimento cognitivo leve amnéstico (CCL amnéstico), doença de Alzheimer (DA) e demência vascular (DV). Métodos: Os dados foram obtidos a partir do banco de dados do ambulatório de demência do Hospital de Clínicas de Porto Alegre (HCPA) e incluíram 407 participantes com idade superior a 50 anos (115 controles saudáveis, 41 pacientes com CCL amnéstico, 165 pacientes com DA e 86 pacientes com DV ou demência mista). Curvas ROC foram geradas para detectar os melhores pontos de cortes de CDR-SB. A escolaridade média foi 4 anos. Resultados: Um ponto de corte de CDR-SB ≥0,5 permite identificar corretamente indivíduos com CCL amnéstico de controles normais (sensibilidade de 100% e especificidade de 98,3%). Um ponto de corte ≥4,5 identifica corretamente os pacientes com CCL amnéstico dos pacientes com demência, todos juntos ou separadamente (DA e DV) (sensibilidade de 96,4% e especificidade de 100%) em 96,9% dos indivíduos. Os melhores intervalos de CDR-SB correspondentes aos escores globais de CDR foram de 0,5 a 4,0 para um escore global de 0,5; 4,5 a 8,0 para um escore global de 1,0; 8,5 a 14,0 para um escore global de 2,0; e 14,5 a 18,0 para um escore global de 3,0. Quando aplicados à amostra de validação, os escores variaram de 0,87 a 0,97. Conclusão: O escore CDR-SB apresentou boa validade clínica para detectar e classificar a gravidade de prejuízos cognitivos na população brasileira. / Background: The Clinical Dementia Rating Scale sum of the boxes (CDR-SB) score has been widely used its utility in staging dementia severity and accuracy to detect diagnostic categories in sociodemographic and cultural diverse regions of the world remains untested. Objective: The aim of this study was to evaluate the CDR-SB diagnostic validity in detecting and staging cognitive impairment/dementia in a sample of Brazilian patients with amnestic mild cognitive impairment (aMCI), Alzheimer’s disease (AD), and vascular dementia (VD). Methods: Data were obtained from the Dementia Clinic of Hospital de Clínicas de Porto Alegre (HCPA) database and included 407 participants (115 healthy controls, 41 aMCI, 165 AD and, 86 VD). Receiver operating characteristic curves were generated to detect best CDR-SB cutoffs. Average education was 4 years. Results: A CDR-SB cutoff ≥0.5 was obtained to correctly identify aMCI from normal controls (sensitivity of 100% and specificity of 98.3%). The cutoff ≥4.5 correctly identified aMCI from dementia patients altogether or separately (AD and VD) (sensitivity of 96.4% and specificity of 100%) in 96.9% of the individuals. Optimal ranges of CDR-SB scores corresponding to the global CDR scores were 0.5 to 4.0 for a global score of 0.5, 4.5 to 8.0 for a global score of 1.0, 8.5 to 14.0 for a global score of 2.0, and 14.5 to 18.0 for a global score of 3.0. When applied to the validation sample, scores ranged from 0.87 to 0.97. Conclusion: The CDR-SB showed good clinical validity to detect and classify severity of cognitive impairment a Brazilian population.

Cognitive and affective dysfunctions are frequent but often neglected symptoms in Parkinson’s disease (PD). We developed the screening tool Parkinson neuropsychometric dementia assessment (PANDA) with five cognitive tasks and a short depression questionnaire. Healthy subjects and patients without cognitive impairment (PD), mild cognitive disorder (PD-MCD), or dementia (PDD) were examined. The cognition part had a specificity of 91% and a sensitivity of 90% for PDD and 77% for PDD plus PD-MCD patients. The mood questionnaire also had high sensitivity and specificity. We conclude that the PANDA is an economical, easy-to-use and sensitive tool to detect neuropsychological dysfunctions in PD patients in clinical practice.